Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. VMD

VMD logo
VMD
Viemed Healthcare Inc
12.07 USD
-0.49%

Access earnings results, analyst expectations, report, slides, earnings call, and transcript.

No Data

No Data

VMD Transcript

Viemed Healthcare, Inc. (VMD) Q1 2026 Earnings Call Transcript
Positive5-6

The company demonstrates strong financial performance with a 28% revenue increase and improved free cash flow. Despite regulatory challenges, the guidance is optimistic, supported by strategic growth in sleep and maternal health sectors. The share repurchase program signals confidence in long-term value. Positive sentiment is further reinforced by analysts' acknowledgment of potential upside in guidance. However, near-term pressures from NCD criteria and seasonal revenue patterns temper enthusiasm, resulting in a positive, yet moderate, stock price outlook.

Savaria Corporation (SIS:CA) Q4 2025 Earnings Call Transcript
Positive3-5

The earnings call summary indicates strong financial performance, with significant increases in revenue, net earnings, and EPS. The Q&A session reveals some uncertainties, but management's optimism about margin expansion and strategic acquisitions suggests positive sentiment. The combination of strong financial metrics, optimistic future guidance, and strategic growth plans supports a positive stock price outlook.

Viemed Healthcare, Inc. (VMD) Q4 2025 Earnings Call Transcript
Positive3-5

The company reported strong financial results with record revenue growth, especially in the sleep and maternal health segments, and maintained stable margins. The strategic focus on expanding the Lehan acquisition and efficient capital allocation is promising. Despite some concerns about RTs and margin stability, the positive growth outlook and shareholder returns suggest a positive stock movement. The lack of market cap information limits precise impact prediction, but overall sentiment leans positive.

Viemed Healthcare, Inc. (VMD) Q3 2025 Earnings Call Transcript
Positive11-7

The company reported strong financial performance with 24% revenue growth and a 22.4% EBITDA margin. Positive factors include raised guidance, successful acquisitions, and increased share repurchases. Concerns about competitive bidding and unclear management responses in the Q&A may temper enthusiasm slightly, but overall sentiment remains positive due to growth and strategic initiatives.

VMD Slides

PDFViemed Q1 2026 slides: 28% revenue growth masks earnings miss
2026-05-05

VMD Report

VIEMED HEALTHCARE, INC. 10-Q
10-Q
2024-08-07
VIEMED HEALTHCARE, INC. 10-Q
10-Q
2024-05-06
VIEMED HEALTHCARE, INC. 10-K
10-K
2024-03-06
VIEMED HEALTHCARE, INC. 10-Q
10-Q
2023-11-01

Frequently Asked Questions

Where does this earnings call transcript come from?

All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.

How soon is the transcript available after the earnings call ends?

Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.

Is the transcript edited or altered in any way?

No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.

Why do some answers appear as “Unclear” or “Inaudible”?

When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.

Who creates the AI Summary and Key Q&A highlights shown above the transcript?

They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.

Explore More Earnings

PENG logo
PENG
2026-07-07 16:05:00
after hour
After Hours
Revenue
$478.71M
+10.05%
EPS
-$0.71
+12.70%
AI Prediction
-
AI Summary
Calendar ReportReport
KRUS logo
KRUS
2026-07-07 16:06:00
after hour
After Hours
Revenue
$85.92M
-0.40%
EPS
-$0.03
+160.00%
AI Prediction
-
AI Summary
Calendar ReportReport
SAR logo
SAR
2026-07-07 16:24:00
after hour
After Hours
Revenue
$30.78M
-2.82%
EPS
-$0.47
-12.96%
AI Prediction
-
Calendar ReportReport
EPAC logo
EPAC
2026-07-07 17:04:00
after hour
After Hours
Revenue
$167.55M
+1.86%
EPS
-$0.60
+22.45%
AI Prediction
-
Calendar ReportReport
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia